-
Animal & Veterinary
-
Cattle
Beef Cattle (Feedlot)
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Chlortetracycline | N046-699 | Type C | For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. |
| Chlortetracycline | N046-699 | Type C | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. |
| Chlortetracycline | N046-699 | Type C | For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. |
| Monensin | N095-735 | Type B | For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii; improved feed efficiency. |
| Monensin | N095-735 | Type B | For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, improved feed efficiency. |
| Monensin | N095-735 | Type C | For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii. |
| Monensin | N095-735 | Type C | For improved feed efficiency. |
| Monensin | N095-735 | Type C | For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii |
| Monensin | N095-735 | Type C | For improved feed efficiency. |
| Monensin (Liquid) | N095-735 | Type B | For improved feed efficiency. |
| Monensin (Liquid) | N095-735 | Type B | For improved feed efficiency. |
| Monensin and Tylosin Phosphate | N104-646 | Type B | For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes |
| Monensin and Tylosin Phosphate | N104-646 | Type B | For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes |
| Monensin and Tylosin Phosphate | N104-646 | Type C | For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. |
| Monensin and Tylosin Phosphate | N104-646 | Type C | For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. |
| Monensin and Tylosin Phosphate (Liquid) | N104-646 | Type B | For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes |
| Monensin and Tylosin Phosphate (Liquid) | N104-646 | Type B | For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes |
| Zilpaterol Hydrochloride | N141-258 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. |
| Zilpaterol Hydrochloride | N141-258 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness during the last 20 to 40 days on feed |
| Zilpaterol Hydrochloride (Liquid) | N141-258 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness during the last 20 to 40 days on feed |
Calves
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Amprolium | N012-350 | Type B | An aid in the prevention and treatment of coccidiosis caused by Eimeria bovis and E. zurnii in calves |
| Amprolium | N012-350 | Type C | An aid in the prevention and treatment of coccidiosis caused by Eimeria bovis and zurnii in calves. |
| Chlortetracycline | N046-699 | Type C | For an increased rate of weight gain and improved feed efficiency in calves between 250 and 400 lbs. |
| Chlortetracycline | N046-699 | Type C | For an increased rate of weight gain and improved feed efficiency in calves up to 250 Ibs. |
| Monensin | N095-735 | Type C | For calves (excluding veal calves): the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii. |
| Oxytetracycline | N138-938 | Type B | For an increased rate of weight gain; improved feed efficiency; treatment of bacterial enteritis caused by Escherichia coli |
| Oxytetracycline | N138-938 | Type C | For treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline in calves for use in calf milk replacers or starter feeds |
| Oxytetracycline | N138-938 | Type C | For an increased rate of weight gain and improved feed efficiency in calves up to 250 lbs |
| Oxytetracycline | N138-938 | Type C | For an increased rate of weight gain and improved feed efficiency in calves up to 250 lbs for use in calf milk replacers or starter feeds. |
| Oxytetracycline | N138-938 | Type C | For an increased rate of weight gain, and improved feed efficiency in calves weighing 250 - 400 lbs |
Cattle (Multiple Classes)
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Chlortetracycline | N046-699 | Type C | Calves, beef, and non-lactating dairy cattle: For treatment of bacterial enteritis caused by Escherichia coli and for bacterial pneumonia caused by Pasteurella multocida organisms. |
| Chlortetracycline | N048-761 | Type C | Beef and non-lactating dairy cattle: as an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline |
| Melengestrol Acetate and Laslocid | A200-451 | Type C | For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat) in heifers |
| Melengestrol Acetate and Laslocid with Tylosin | A200-430 | Type C | For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat) in heifers |
| Oxytetracycline | N138-938 | Type B | For an increased rate of weight gain; improved feed efficiency; reduction of liver condemnation due to liver abscesses; prevention and treatment of the early stages of shipping fever complex; treatment of bacterial enteritis and bacterial pneumonia... |
| Oxytetracycline | N138-938 | Type C | For the prevention and treatment of the early stages of the shipping fever complex |
| Oxytetracycline | N138-938 | Type C | For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida organisms susceptible to oxytetracycline in calves, beef and non-lactating dairy cattle |
| Poloxalene | N032-704 | Type C | For prevention of legume (alfalfa, clover) and wheat pasture bloat in cattle. |
| Tylosin Phosphate | N012-491 | Type B | For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. |
| Tylosin Phosphate | N012-491 | Type C | For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. |
| Tylosin Phosphate (Liquid) | N012-491 | Type B | For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes |
Dairy Cattle
| Active Ingredient |
NADA/ANADA |
Label Type | Indications |
|---|---|---|---|
| Monensin (Liquid) | N095-735 | Type B | For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). |
| Monensin | N095-735 | Type B | For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). |
| Monensin | N095-735 | Type C | For total mixed rations: increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). |
| Monensin | N095-735 | Type C | For component feeding systems (including top dress): increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). |
Growing Cattle
| Active Ingredient |
NADA/ANADA |
Label Type | Indications |
|---|---|---|---|
| Bacitracin Zinc | A200-223 | Type B | For an increased rate of weight gain and improved feed efficiency. |
| Bacitracin Zinc | A200-223 | Type C | For an increased rate of weight gain and improved feed efficiency. |
| Chlortetracycline | N046-699 | Type C | For an increased rate of weight gain, improved feed efficiency and reduction of liver condemnation due to liver abscesses in growing cattle over 400 lbs. |
| Monensin | N095-735 | Type B | For increased rate of weight gain; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers). |
| Monensin | N095-735 | Type C | For increased rate of weight gain; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers). |
| Oxytetracycline | N138-938 | Type C | For increased weight gain, improved feed efficiency, and reduction of liver condemnation due to liver abscesses in growing cattle over 400 lbs |
Reproducing Beef Cattle
| Active Ingredient | NADA/ANADA | Label Type | Indications |
|---|---|---|---|
| Monensin | N095-735 | Type B | For mature reproducing beef cows (on pasture or in dry lot): improved feed efficiency when receiving supplemental feed; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii. |
| Monensin | N095-735 | Type C | For mature reproducing beef cows (on pasture or in dry lot): improved feed efficiency when receiving supplemental feed; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii. |
-
-